Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase. - Wikidata - wikimedia - TriplyDB

Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase.

Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase.

http://www.wikidata.org/entity/Q34205763

about

Future pharmacological treatments for substance use disorders The Involvement of Norepinephrine in Behaviors Related to Psychostimulant Addiction Role of cues and contexts on drug-seeking behaviour Cocaine increases dopaminergic neuron and motor activity via midbrain α1 adrenergic signaling.Human Bacterial Artificial Chromosome (BAC) Transgenesis Fully Rescues Noradrenergic Function in Dopamine β-Hydroxylase Knockout Mice Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans Noradrenergic α₁ receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial Chronic inhibition of dopamine β-hydroxylase facilitates behavioral responses to cocaine in mice Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.Effects of pharmacologic dopamine β-hydroxylase inhibition on cocaine-induced reinstatement and dopamine neurochemistry in squirrel monkeys.Novel pharmacotherapeutic treatments for cocaine addiction.Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease The galanin receptor agonist, galnon, attenuates cocaine-induced reinstatement and dopamine overflow in the frontal cortex.Chronic loss of noradrenergic tone produces β-arrestin2-mediated cocaine hypersensitivity and alters cellular D2 responses in the nucleus accumbens Long-term γ-hydroxybutyric acid (GHB) and disulfiram combination therapy in GHB treatment-resistant chronic alcoholics.Transcription factor Phox2 upregulates expression of norepinephrine transporter and dopamine β-hydroxylase in adult rat brains The effects of post-extinction exercise on cocaine-primed and stress-induced reinstatement of cocaine seeking in rats Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawal Evaluating the Impact of Naltrexone on the Rat Gambling Task to Test Its Predictive Validity for Gambling Disorder.Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine.Neuronal copper homeostasis susceptibility by genetic defects in dysbindin, a schizophrenia susceptibility factor.S-(N, N-diethylcarbamoyl)glutathione (carbamathione), a disulfiram metabolite and its effect on nucleus accumbens and prefrontal cortex dopamine, GABA, and glutamate: a microdialysis study.Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial.Operant psychostimulant self-administration in a rat model of depression Adding Genetic Testing to Evidence-Based Guidelines to Determine the Safest and Most Effective Chronic Pain Treatment for Injured Workers Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder.The selective dopamine β-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behavior The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study.Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin.Specificity and impact of adrenergic projections to the midbrain dopamine system.Effects of disulfiram on QTc interval in non-opioid-dependent and methadone-treated cocaine-dependent patients.Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation.Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot Study.Dopamine β-hydroxylase inhibitors enhance the discriminative stimulus effects of cocaine in rats.Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease.

P2860

Q22242633-FBB93036-3BF4-4C06-A075-3089FA49A238 Q26786261-FBDEBF11-558A-4023-BB82-98E1BA1FE6C5 Q26825476-3A7EDE56-3BBA-4737-BCAC-D314C2B79018 Q27311149-8ECFC844-5A79-4F6B-BAB1-E0BCC881CCB4 Q28115881-03937FC8-EF97-45D4-86B9-50EFFD3A6140 Q28265682-F928FFCC-11DA-4737-AA72-567EAE55BEA3 Q28265851-0C907667-AF5A-4D59-9CE5-541FCFE49DC2 Q28480500-5B6AA84C-2B0A-4A03-A8B4-500836E3F4F6 Q28485338-46AB0948-6BD9-45F4-A54A-92417B58A7D2 Q33582063-7C0EB8B4-A0F2-407A-83A6-5D844AFCC3F4 Q33750819-76D292A2-6072-4C9E-A60D-7E7D328A9F97 Q34065088-8737722D-9E6D-4A50-8590-CA53747282CD Q34253787-453D3F92-CFA2-4129-BA88-55C7A45EA11D Q34277168-1DA0C4AF-35F7-48A0-A9DF-DAA37671FD1C Q34572608-B0C8D409-7D83-4D31-A83F-BC06519FCC02 Q35008017-C7E8E624-FFAB-4A52-B280-00F008DA2D22 Q35079713-8C4D99C4-53A5-428C-83F1-FE5CBE025BDE Q35162034-023B453A-5C84-47A7-8759-BC7DE613B532 Q35194612-A23F64D9-B60D-4B5B-BB2A-44C788FCF4C6 Q35305319-182889EE-3A09-4D68-9937-265E72C35367 Q35589974-8B9F8B7E-3B43-4CF8-AEE3-19E339323E46 Q36021014-BE572BC5-A0EF-414C-AC88-582F076271E0 Q36036175-C2546092-EA48-4C73-8449-0AEA534117BF Q36065482-252B729F-C2B8-431F-81F5-2B176ADE254B Q36243255-F75951E8-31EA-4DDF-B07A-418010072AA3 Q36287820-434A6559-FC5F-4A2A-95BB-269CB4BB5155 Q36384712-91E16EEF-9993-4207-A60B-8E38287C3C39 Q36389062-71EAB8B9-8636-4D9C-A82A-8721AE72E82A Q36424264-8C801ADB-57A3-4B1B-A886-EE84F2B08931 Q36446037-30DB1C38-2C6C-43B3-9A5B-059684BE84D6 Q36650526-029DADE3-4084-4DB2-ADAD-4A57CEC7D317 Q36775245-FA1C9AFF-270D-4105-9C48-5D74268F7089 Q36847296-132E94AB-1966-4406-A38B-CE8AEAD6493A Q36922331-BC24FE24-E8F6-4148-90A1-9AE769CCD107 Q36932568-846AE1D9-BF7F-4376-B686-47BFF74E273C Q37079673-D361EDE4-BC12-4B04-A0AC-84AB476B77D0 Q37282486-92C414C2-DA3D-4B34-85C7-24B349F76702 Q37329522-940E7695-10DA-4B9F-9D7E-FE664E72314D Q37331807-7B4ECB3D-413E-4ACF-B8F2-F771F1D732E1 Q37634353-4C4B62B2-6F45-4624-8001-D15E74DCB040

P2860

Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase.

http://www.wikidata.org/entity/Q34205763

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Disulfiram attenuates drug-pri ...... ion of dopamine β-hydroxylase.

@ast

Disulfiram attenuates drug-pri ...... ion of dopamine β-hydroxylase.

@en

Disulfiram attenuates drug-pri ...... ion of dopamine β-hydroxylase.

@nl

type

label

Disulfiram attenuates drug-pri ...... ion of dopamine β-hydroxylase.

@ast

Disulfiram attenuates drug-pri ...... ion of dopamine β-hydroxylase.

@en

Disulfiram attenuates drug-pri ...... ion of dopamine β-hydroxylase.

@nl

prefLabel

Disulfiram attenuates drug-pri ...... ion of dopamine β-hydroxylase.

@ast

Disulfiram attenuates drug-pri ...... ion of dopamine β-hydroxylase.

@en

Disulfiram attenuates drug-pri ...... ion of dopamine β-hydroxylase.

@nl

P1433

Q34205763-F290867E-E62C-4A55-9ABE-EDC061BEDDFC

P1476

Q34205763-6C3EE8FA-5986-4711-88A3-D13B6867E9DB

P2093

Q34205763-0EB49DFD-520A-48BC-80E4-113020B15CDD

Q34205763-108408B3-5136-44E3-A560-CDCBB36E3E73

Q34205763-345E3E16-EB97-4475-88C4-8009CE363A4E

Q34205763-35188307-EAAB-49E4-822D-43A6B8E0A73C

Q34205763-48F589FA-6CAB-4C65-93C9-0002F9C7A41B

Q34205763-78DA2321-EFD8-44D4-B1A7-52E07AF7F714

Q34205763-94E74FA7-8586-4C40-AD68-8DA4AD79586D

Q34205763-C28D03AE-6724-43DF-89CF-B699FDC50DAE

Q34205763-C4C4EF1C-8A21-4B01-A041-4131BF0D5BA4

Q34205763-D1D3EAB0-16B4-4102-8CEB-C55EAF46B95B

P2860

Q34205763-04375E2F-BF34-447F-86E1-84DB1BE8682A

Q34205763-09B8100E-DA80-4D25-8CED-B508BB497BB0

Q34205763-11376329-A13D-4062-816B-EC433B0F39CA

Q34205763-1966D2EB-B621-4F87-8B4B-6C63D240B26A

Q34205763-1F7C06EB-A4F8-4BD8-B58A-FAE1DB09DE0F

Q34205763-268E94FD-082D-4147-989F-DC0C00ADCE75

Q34205763-26BA111A-61D4-4B36-9871-5A58947078CB

Q34205763-29CC68ED-0F13-450F-B417-CBCE5684D1C3

Q34205763-2A1F0E54-CD4D-4569-AC1D-D78366AC827B

Q34205763-2B5015F6-8AF5-4B7D-BADB-404EC860B7ED

P2888

Q34205763-83171B7B-0AB5-46B5-827E-294524B53E45

P304

Q34205763-3FDD1350-6BE8-414E-82B7-F54F288AF471

P31

Q34205763-AF587366-CEA7-434A-8818-84F680B4D7C6

P356

Q34205763-09F579B3-05E3-4BF8-8283-1247D2F099DB

P407

Q34205763-97A58D0C-32A6-4D8E-8951-3F3E7FD396BE

P433

Q34205763-3D738CD7-F355-4CD9-93BA-E5239E522527

P478

Q34205763-4AE91FD3-8AD4-445F-8A4E-94644DB3C196

P50

Q34205763-F3C5AD7C-C271-4514-975C-E856B4F60A49

P577

Q34205763-AFD76759-D5C9-46A7-B689-398262DDB5B2

P5875

Q34205763-9F065B24-140F-4D41-84FA-D0D09165BD68

P6179

Q34205763-C39374AB-795C-498C-99C7-C757C644130A

P698

Q34205763-2AB7E446-D626-46F5-A8D7-8DF2188A7937

P921

Q34205763-2dab2a62-f27c-46d2-920e-f892170b162e

P932

Q34205763-E0473651-9207-4AF4-B23E-FD1ACFAAF96A

P356

P1433

Neuropsychopharmacology

P1476

Disulfiram attenuates drug-pri ...... tion of dopamine β-hydroxylase

@en

P2093

David Weinshenker

http://www.w3.org/2001/XMLSchema#string

Debra A Cooper

http://www.w3.org/2001/XMLSchema#string

Gaylen L Edwards

http://www.w3.org/2001/XMLSchema#string

Jason P Schroeder

http://www.w3.org/2001/XMLSchema#string

Jesse R Schank

http://www.w3.org/2001/XMLSchema#string

Kimberly G Freeman

http://www.w3.org/2001/XMLSchema#string

Megan A Lyle

http://www.w3.org/2001/XMLSchema#string

Meriem Gaval-Cruz

http://www.w3.org/2001/XMLSchema#string

Nikita Pozdeyev

http://www.w3.org/2001/XMLSchema#string

P Michael Iuvone

http://www.w3.org/2001/XMLSchema#string

P2860

Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase

Role of the increased noradrenergic neurotransmission in drug self-administration

A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia

Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts

Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates

The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking.

Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial.

Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism.

mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse

Disulfiram treatment of alcoholism. A Veterans Administration cooperative study.

P2888

P304

2440-2449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2010.127

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Yvonne E Ogbonmwan

P577

2010-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45828217

http://www.w3.org/2001/XMLSchema#string

P6179

1036175062

http://www.w3.org/2001/XMLSchema#string

P698

20736996

http://www.w3.org/2001/XMLSchema#string

P921

P932

2956132

http://www.w3.org/2001/XMLSchema#string